Price Alert

AbbVie Inc. (ABBV)

NYSE: ABBV · Real-Time Price · USD

206.48

-0.21 (-0.10%)

At close: Aug 18, 2025, 3:59 PM

207.41

0.45%

Pre-market: Aug 19, 2025, 04:08 AM EDT

AbbVie Statistics

Share Statistics

AbbVie has 1.77B shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	1.77B
Shares Change (YoY)	0%
Shares Change (QoQ)	-0.15%
Owned by Institutions (%)	71.15%
Shares Floating	1.76B
Failed to Deliver (FTD) Shares	186
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 15.61M, so 0.88% of the outstanding shares have been sold short.

Short Interest	15.61M
Short % of Shares Out	0.88%
Short % of Float	0.88%
Short Ratio (days to cover)	2.61

Valuation Ratios

The PE ratio is 73.48 and the forward PE ratio is 13.88. AbbVie's PEG ratio is -6.08.

PE Ratio	73.48
Forward PE	13.88
PS Ratio	5.58
Forward PS	5.3
PB Ratio	94.54
P/FCF Ratio	17.63
PEG Ratio	-6.08

Financial Ratio History

Enterprise Valuation

AbbVie has an Enterprise Value (EV) of 376.67B.

EV / Sales	6.69
EV / EBITDA	25.26
EV / EBIT	20.03
EV / FCF	21.12

Financial Position

The company has a current ratio of 0.66, with a Debt / Equity ratio of 20.4.

Current Ratio	0.66
Quick Ratio	0.55
Debt / Equity	20.4
Debt / EBITDA	4.55
Debt / FCF	3.8
Interest Coverage	3.25

Financial Efficiency

Return on Equity is 128.66% and Return on Invested Capital is 10.21%.

Return on Equity	128.66%
Return on Assets	3.17%
Return on Invested Capital	10.21%
Revenue Per Employee	$1.02M
Profits Per Employee	$77.78K
Employee Count	55,000
Asset Turnover	0.42
Inventory Turnover	4.04

Taxes

Income Tax	-570M
Effective Tax Rate	-15.34%

Stock Price Statistics

The stock price has increased by 4.44% in the last 52 weeks. The beta is 0.5, so AbbVie's price volatility has been higher than the market average.

Beta	0.5
52-Week Price Change	4.44%
50-Day Moving Average	189.63
200-Day Moving Average	188.03
Relative Strength Index (RSI)	60.62
Average Volume (20 Days)	6,132,690

Income Statement

In the last 12 months, AbbVie had revenue of 56.33B and earned 4.28B in profits. Earnings per share was 2.4.

Revenue	56.33B
Gross Profit	39.43B
Operating Income	9.14B
Net Income	4.28B
EBITDA	14.91B
EBIT	6.52B
Earnings Per Share (EPS)	2.4

Full Income Statement

Balance Sheet

The company has 5.52B in cash and 67.84B in debt, giving a net cash position of -62.32B.

Cash & Cash Equivalents	5.52B
Total Debt	67.84B
Net Cash	-62.32B
Retained Earnings	-7.9B
Total Assets	136.16B
Working Capital	-8.73B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 18.81B and capital expenditures -974M, giving a free cash flow of 17.83B.

Operating Cash Flow	18.81B
Capital Expenditures	-974M
Free Cash Flow	17.83B
FCF Per Share	10.08

Full Cash Flow Statement

Margins

Gross margin is 69.99%, with operating and profit margins of 16.22% and 7.59%.

Gross Margin	69.99%
Operating Margin	16.22%
Pretax Margin	6.6%
Profit Margin	7.59%
EBITDA Margin	26.47%
EBIT Margin	16.22%
FCF Margin	31.65%

Dividends & Yields

ABBV pays an annual dividend of $8.02, which amounts to a dividend yield of 3.47%.

Dividend Per Share	$8.02
Dividend Yield	3.47%
Dividend Growth (YoY)	5.81%
Payout Ratio	381.9%
Earnings Yield	1.36%
FCF Yield	5.67%

Dividend Details

Analyst Forecast

The average price target for ABBV is $211, which is 6.2% higher than the current price. The consensus rating is "Buy".

Price Target	$211
Price Target Difference	6.2%
Analyst Consensus	Buy
Analyst Count	20

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$12
Lynch Upside	-93.96%
Graham Number	10.11
Graham Upside	-94.91%

Scores

Altman Z-Score	1.95
Piotroski F-Score	5